Azitra Advances ATR-04 Phase 1/2 Clinical Trial to Cohort 2

Filing content

The company announced the completion of Cohort 1 in its Phase 1/2 trial for ATR-04 and is proceeding to enroll and dose patients in Cohort 2 following safety committee clearance.